DexCom’s fair value price target has been tweaked from US$85.85 to US$86.12 per share, a small shift that still matters if you are tracking what analysts are baking into their models. This move sits ...

In 2026, consumer wearables do more. They can flag patterns that may point to real health problems, not just a rough wellness trend.

Opportunities include integrating digital health for remote care, leveraging demographic trends, and overcoming CGM unit costs to expand access across regionsDublin, March 16, 2026 (GLOBE NEWSWIRE) -- ...

People don't buy consumer wearables just to count steps anymore. They want early warnings, useful health signals, and features they can trust.

Diabetes Care Devices Market Insights, Competitive Landscape, and Market Forecast - 2034” report provides the current ...

At ATTD 2026, Dexcom (Nasdaq:DXCM) outlined a range of ways in which its continuous glucose monitors (CGMs) benefit people ...

Diabetes technology innovators gathered last week for the Advanced Technologies and Treatments for Diabetes Conference (ATTD ...

The diabetes care devices market is largely propelled by the increasing global incidence of diabetes, which is influenced by higher obesity rates, sedentary habits, and an aging population. Heightened ...

The diabetes care devices market is largely propelled by the increasing global incidence of diabetes, which is influenced by higher obesity rates, sedentary habits, and an aging population.